Healthcare Costs of Post-Prostate Biopsy Sepsis.
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
05
03
2019
revised:
11
05
2019
accepted:
13
06
2019
pubmed:
24
6
2019
medline:
17
1
2020
entrez:
24
6
2019
Statut:
ppublish
Résumé
Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.
Identifiants
pubmed: 31229516
pii: S0090-4295(19)30550-3
doi: 10.1016/j.urology.2019.06.011
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-15Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.